Skip to main content
👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources. Claim this profile →
Dr Sarah Jefferies
Trust score 8/100 Accepting new patients

Dr

Dr Sarah Jefferies

Oncology

English
12,847+ Patients seen
15 Years in practice
13 Publications
1 Languages spoken

About

Dr Sarah Jefferies graduated from University College London Medical School London in 1989. She joined the Royal Marsden Hospital in 1993 as a Specialist Registrar, after which she undertook a PhD investigating the role of genetic factors in the development of multiple primary tumours after an index squamous cell carcinoma of the head and neck at the Institute of Cancer Research, London. Dr Jefferies completed her training at the Middlesex Hospital, London. She was appointed as a consultant at Addenbrooke's Hospital, Cambridge in 2002 and has since led service development for CNS and skull base tumours working closely with neurosurgical teams to establishment site-specific multi-disciplinary teams and NICE-compliant referral and treatment pathways.

Dr Jefferies is committed to improving outcomes in brain tumours and is principal investigator for a portfolio of clinical trials in this field. She is also a member of the European Organisation for Research and Treatment of Cancer (EORTC) Brain Tumour Group and the National Cancer Research Network (NCRN) Brain Clinical sub-group. Dr Jefferies is also research lead for the Eastern CRN for neuro-oncology.

Dr Jefferies has been instrumental in establishing molecular testing of glioma's which are now used in routine clinical practice. Dr Jefferies provides teaching on the management of CNS tumours for local, national and on European Society for Therapeutic Radiation Oncology (ESTRO) courses. She has authored over 50 scientific papers and also examines MD and PhD projects for a number of universities. Dr Jefferies provides peer review for a number of journals and was a member of the CTAAC committee from 2010 to 2015.

She continues to practice head and neck and thyroid cancer delivering radiotherapy, chemotherapy and radioiodine therapies at Addenbrooke's Hospital.

Diseases, Medical Tests and Treatments
• Image guided radiotherapy

• Radiotherapy

• Stereotactic ablative radiotherapy (SABR)

• Thyroid Cancer

• CNS Tumours

“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”

— Dr Sarah Jefferies

Education & training

  1. 2001–2007 MD · Medicine and Surgery
    Universitat de València
  2. 2007–2011 Residency · Oncology
    Universidad de Navarra

Career & appointments

  1. 2011-09–2012-08 Junior consultant
    Universitat de València Teaching Hospital — Oncology

Licenses & insurance

Medical licenses

— Organización Médica Colegial de España (OMC)
#-268292 active · expires 2028-12-31

Board certifications

European Board of Oncology
#EB-72C0A652 · issued 2012 · renewal 2022
Malpractice insurance: HDI Global · 2,000,000 EUR coverage · No claims on file

Procedures performed

ProcedureCodeLifetime count
GP consultation 99213 1,172
Annual physical exam 99395 1,722
Vaccination administration 90471 2,970
Minor procedure (skin) 17110 1,013

Services & pricing

ServiceDurationModalityPrice
New patient consultation (60m) 60 min in_clinic|telemed 180.00 EUR
Follow-up consultation (30m) 30 min in_clinic|telemed|phone 90.00 EUR
Vaccination administration 120 min in_clinic 540.00 EUR
Minor procedure (skin) 30 min in_clinic 810.00 EUR

Office, team & in practice

Sarah Jefferies
HEADSHOT
Sarah Jefferies in consultation
IN OFFICE
Sarah Jefferies with the team
WITH TEAM
Sarah Jefferies at a conference
CONFERENCE

Videos

introduction · 144s
Meet Sarah Jefferies

Research & publications

h-index: 16 · i10: 12

  1. Long-term follow-up of Oncology across
    Sarah Jefferies, et al. · European Journal of Medicine, 2026
    DOI: 10.4148/euroclin.2026.0 · PMID: 30789598 · cited by 44
  2. Validation of clinical scoring in Oncology
    Sarah Jefferies, et al. · European Journal of Medicine, 2025
    DOI: 10.1386/euroclin.2025.1 · PMID: 37208723 · cited by 54

Invited talks

  • Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
  • Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract

Awards & memberships

Awards

  • 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional

Society memberships

  • WONCA Europe — Family Doctors — Member · since 2012
  • national college of family doctors — Member · since 2012
  • European Union of Medical Specialists (UEMS) — Member · since 2012

Patient reviews

★ 0.00 1,000 verified reviews
Bedside Manner
0.05
Knowledge
0.08
Wait Time
3.80
Staff Friendliness
0.02
Ease Of Appointment
4.00
Value For Money
4.10
Would Recommend Pct
4
  • ★ 5 verified visit

    “Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”

    — Anna B. · 2026-05-07

  • ★ 5 verified visit

    “Took time to listen and reviewed all my previous results. I would absolutely recommend.”

    — Marco V. · 2026-04-10

  • ★ 4 verified visit

    “Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”

    — Helena F. · 2026-04-09

Articles by this doctor

  • Patient education Patient guide to Oncology
  • Awareness When should you see a oncology?

For international patients

Coordinator
Patient liaison · sarah.jefferies@euroclinics.example

Similar specialists

Browse all →